Assessing the effects of a novel intervention for antiretroviral medication adherence by Champassak, Sofie Ling
 ASSESSING THE EFFECTS OF A NOVEL INTERVENTION FOR ANTIRETROVIRAL 
MEDICATION ADHERENCE 
 
 
 
A DISSERTATION IN 
Psychology 
 
Presented to the Faculty of the University 
of Missouri-Kansas City in partial fulfillment of 
the requirements for the degree 
 
DOCTOR OF PHILOSOPHY 
 
 
 
by 
Sofie Ling Champassak 
B.A., San Diego State University, 2010 
M.A., University of Missouri-Kansas City, 2012 
 
 
 
 
 
Kansas City, Missouri 
2016
 ii 
 
 iii 
ASSESSING THE EFFECTS OF A NOVEL INTERVENTION FOR ANTIRETROVIRAL 
MEDICATION ADHERENCE 
 
Sofie Ling Champassak, Candidate for the Doctor of Philosophy Degree 
University of Missouri-Kansas City 2015 
 
ABSTRACT 
 
The use of antiretroviral therapy (ART) has led to substantial declines in morbidity 
and mortality in patients with HIV, however the benefits of ART are largely dependent on 
strict adherence.  Effective interventions have been developed to improve adherence that 
include the use of cognitive behavioral treatment techniques or external supports such as 
modified directly observed therapy (mDOT).  Project MOTIV8 assessed whether a novel 
intervention combining motivational interviewing based cognitive behavioral therapy (MI-
CBT) counseling with modified directly observed therapy (mDOT) was more effective than 
MI-CBT counseling alone or standard care (SC) for increasing ART adherence (Goggin et al., 
2013).  The results demonstrated an interaction effect such that the combined MI-
CBT/mDOT group had its greatest effect at week 12 of the intervention, and then adherence 
rates declined more rapidly than the SC and MI-CBT groups as the intervention concluded. 
The aim of this study was to enhance our understanding of the intervention effects found in 
Project MOTIV8 by identifying how mediator variables were impacted by treatment 
throughout the course of the study.  Treatment was based primarily on the Information-
Motivation-Behavioral Skills Model and included variables that measured participants’ 
 iv 
adherence information (knowledge about ART), adherence motivation (personal and 
perceptions of significant others’ attitudes and beliefs that impact patients’ motivation), and 
adherence behavioral skills (e.g., acquiring medications and social support for adherence). 
Data for this secondary data analysis comes from Project MOTIV8 and was collected at 
baseline, week 24, and week 48.  Participants were recruited from six outpatient clinics and 
stratified by ART experience and clinic.  Data from 204 participants were available for 
analysis.  Participants were on average 40 years old, 76% were male, and 57% were African 
American.  A total of 14 mediator variables were measured throughout the course of the 
intervention.  A principal components analysis (PCA) was used to reduce the number of 
variables and structural equation modeling (SEM) was used to determine which mediator 
variables were impacted by treatment and which mediator variables predicted adherence. The 
results of the PCA identified three latent IMB constructs which included 11 of the 14 
mediator variables.  The results of a SEM analysis revealed that mDOT significantly 
decreased participants’ adherence information and increased adherence motivation at the end 
of treatment.  However these effects weren’t found during the 6-month follow-up.  There 
were no significant effects found between MI-CBT and any of the IMB constructs. Only 
adherence motivation had a significant positive effect on adherence at the 6-month follow-up.  
These findings provide direction for improving treatment and advancing treatment research. 
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CHAPTER 1 
INTRODUCTION  
The use of antiretroviral therapy (ART) has been shown to suppress viral load, increase 
rates of survival and improve quality of life in patients with HIV.  High levels of adherence (≥ 
90%) are required for these benefits and are challenging and often not sustained over time.  
Average rates of ART adherence have been found to be between 50 and 70% (Krummenacher, 
Cavassini, Bugnon, & Schneider, 2011).  Many factors contribute to low levels of adherence 
including individual factors (e.g., knowledge, motivation), factors related to the medications (e.g., 
side-effects, perceived difficulty of regimen), and environmental factors (e.g., access to care, 
adherence support).  
To address these barriers, effective interventions have targeted various factors to increase 
rates of adherence.  Previous studies have tested the effect of comprehensive ART adherence 
using counseling interventions that include motivational interviewing (MI) and cognitive 
behavioral treatment (CBT) techniques while other studies have included external supports such 
as modified directly observed therapy (mDOT).  These approaches have demonstrated some 
promise in improving ART adherence (Altice, Maru, Bruce, Springer, and Friedland, 2007; 
Amico, Harman, & Johnson, 2006; Golin, Earp, Tien, Stewart, Porter, & Howie, 2006; Hart, 
Jeon, Ivers, Behforouz, Caldas, Drobac, & Shin, 2010).   
To date, only one study, Project MOTIV8, has examined the combined effect of 
motivational interviewing-based cognitive behavioral therapy (MI-CBT) counseling with mDOT 
approaches (Goggin, Gerkovich, Williams, Banderas, Catley, Berkley-Patton, Wagner, Stanford, 
Neville, Kumar, Bamberger, & Clough, 2013).  This study assessed the efficacy of MI-CBT 
counseling combined with mDOT compared to MI-CBT counseling alone or standard care (SC) 
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to impact ART adherence. Findings included a significant interaction of group by time, but no 
main effect of group.  Post hoc analyses of the significant interaction revealed only trends for 
differences between groups at week 12.  Specifically the combined MI-CBT/mDOT intervention 
group had the highest average adherence at week 12, and then saw a steady decline to rates 
below the SC and MI-CBT groups as the study concluded.  
There are at least a couple of reasons why efficacy studies fail to demonstrate significant 
main effects.  Either the interventions were ineffective in impacting the theoretical mediators of 
the outcome or the theoretical mediators had no impact on the outcome.  Evaluating theoretical 
mediators is of vital importance for increasing understanding of theoretical mediators and 
improving the efficiency and effectiveness of interventions (Glasgow, 2002).  Unfortunately, 
despite the significant number of ART adherence trials, there is a lack of published research in 
which the role of mediators is explored (Leeman, Chang, Voils, Crandell, & Sandelowski, 2011).  
Theoretical Perspective 
 This study’s interventions were based on the Information-Motivation-Behavioral Skills 
(IMB) model of behavior change, (Fisher & Fisher, 1992; Fisher, Fisher, Misovich, Kimble, & 
Malloy, 1996) which suggests that information is a prerequisite to modify behavior but is not 
sufficient alone.  According to this model, critical components to promote behavior change also 
include a person’s motivation and behavioral skills.  Information and motivation work together 
through behavior skills to affect behavior, although information and motivation can also 
independently directly influence behavior (Figure 1).  The IMB model has been applied to the 
development of adherence interventions to demonstrate effective behavior change across a 
variety of clinical applications including HIV medication adherence and self-care behaviors in 
adults with type 2 diabetes (Carey, Maisto, Kalichman, Forsyth, Wright, & Johnson, 1997; 
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Fisher & Fisher, 1992; Fisher, Fisher, Misovich, Kimble, & Malloy, 1996; Gao, Wang, Zhu, & 
Yu, 2013; Mayberry & Osborn, 2014; Gavgani, Poursharifi, & Aliasgarzadeh, 2010; Rongkavilit 
et al., 2010; Walsh, Senn, Scott-Sheldon, Vanable, & Carey, 2011).  
The goal of the motivational interviewing (MI) intervention components in this study was 
primarily to enhance motivation while the cognitive-behavioral aspects of the intervention were 
intended primarily to enhance knowledge and skills (including self-efficacy) for adherence. The 
theoretical underpinnings of mDOT are unclear, however it was assumed that mDOT would 
ultimately foster adherence skills through repeated prompted practice. 
 
Figure 1. Information-Motivation-Behavioral Skills Model of Adherence 
Based on these intervention goals a number of IMB based mediator variables were 
assessed.  Information variables included knowledge about ART and medication adherence.  
Motivation variables included motivation, readiness and confidence to adhere, autonomous 
regulation, autonomy support, perceived costs and benefits of ART, and perceived social support 
for ART adherence.  Because of the practical difficulty of assessing behavioral adherence skills, 
the study assessed adherence skills indirectly through measures of self-efficacy for adherence, 
perceived difficulty of adherence, and reasons for non-adherence (e.g., a variety of reasons 
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participants may have missed taking their medications related to the patient, medicine, or 
logistics). 
The purpose of this study was to advance understanding of adherence intervention effects 
by exploring the role of IMB based mediator variables in Project MOTIV8.  Specifically the 
study examined the impact of MI-CBT/mDOT relative to MI-CBT and standard care on IMB 
based mediator variables as well as the relationship between changes in mediator variables and 
adherence. 
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CHAPTER 2 
BACKGROUND 
Antiretroviral Therapy (ART) and ART Adherence 
Antiretroviral therapy (ART) is a combination of at least three antiretroviral (ARV) drugs 
to suppress and stop the human immunodeficiency virus (HIV) from reaching the most advanced 
stage of infection known as acquired immunodeficiency syndrome (AIDS; WHO, 2014). 
Adhering to ART can lower the amount of viral load in the body to improve health and prolong 
life in people living with HIV/AIDS (CDC, 2013).  Moreover, good adherence can reduce the 
risk of transmitting HIV to others by over 90% (Attia, Egger, Müller, Zwahlen, & Low, 2009; 
Cohen, Chen, McCauley, et al., 2011).  However, high levels of adherence (≥ 90%) are critical to 
achieve these individual and public health benefits (Chesney, 2006; WHO, 2003). Yet the 
average rates of ART adherence have been found to be between 50 and 70% (Chesney, Ickovics,  
Chambers, Gifford, Neidig, Zwickl, & Wu, 2000; Krummenacher et al., 2011).  Missing doses 
can lead to HIV drug resistance (HIVDR) allowing the virus to mutate and reproduce in the 
presence of ARV drugs (Bangsberg, Moss, & Deeks, 2004).  The consequences of HIVDR 
include treatment failure, increased health care costs associated with the need to start more 
expensive treatments, spreading drug resistant HIV, and the need to develop new anti-HIV drugs 
(WHO, 2014).  
Factors that Contribute to ART Adherence 
There are a variety of factors that contribute to ART adherence including individual, 
medication-related, and environmental factors.  Individual factors such as knowledge of ART 
and treatment regime, neurocognitive impairment, low health literacy, motivation, self-efficacy, 
age, mental illness, and substance use have been shown to be associated with ART adherence 
(Carr & Gramling, 2004; Demessie, Mekonnen, Wondwossen, & Shibeshi, 2014; Halkitis, 
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Shrem, Zade, & Wilton, 2005; Safren et al., 2012; Safren et al., 2009).  Factors related to taking 
ART medication such as number of pills, timing of doses (four, six, eight, or 12 hour intervals), 
side effects, food requirements (some should be taken on an empty stomach, with meals, fatty, or 
non-fatty foods), and dosing complexity have also been shown to be associated with ART 
adherence (Nachega et al., 2014; Raboud et al., 2011; Safren et al., 2001).  Lastly, environmental 
factors such as adherence support, homelessness, access to care, characteristics of the clinical 
setting, and patient-provider relationship have also demonstrated a relationship with ART 
adherence (CDC 2012; Schneider, Kaplan, Greenfield, & Wilson, 2004; Thompson et al., 2012). 
Effective Interventions to Increase ART Adherence 
Cognitive Behavioral Therapy (CBT) Interventions 
To improve adherence, effective interventions have targeted various factors to address 
individual, medication related, and environmental barriers.  Interventions that have used 
counseling techniques such as cognitive behavioral therapy (CBT) have demonstrated some 
success in improving ART adherence (Chaiyachati et al., 2014).  CBT is a form of 
psychotherapy that was developed to treat a variety of mental health disorders and has also been 
found to be effective for treating a variety of health conditions such as chronic pain, sleep 
disorders, and headaches.  Over 300 research studies have been published that have evaluated the 
efficacy of CBT interventions for a wide range of psychiatric disorders and health conditions 
(Butler, Chapman, Forman, & Beck, 2006).  Several of these studies test the efficacy of using 
CBT strategies to improve ART adherence.  For example, a recent systematic review published 
by Chaiyachati et al. (2014) identified 60 intervention studies that utilized CBT techniques to 
improve ART adherence.  Although the effects of CBT on ART adherence have been widely 
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assessed, the findings in the literature continue to be mixed.  Moreover, significant effects tend to 
be small and diminish over time (Simoni, Amico, Smith, & Nelson, 2010).  
For example, several researchers began using CBT in their interventions to focus on 
participants’ individual barriers to adherence.  Interventions have included CBT components 
such as providing advice and education, teaching stress management and coping skills using 
single or multiple sessions in one-on-one or via group settings (Goujard et al., 2003; Jones et al., 
2007; Knobel et al., 1999; Murphy, Lu, Martin, Hoffman, & Marelich, 2002; Rawlings et al., 
2003; Tuldra et al., 2000).  Weber et al. (2004) conducted a one-year trial to examine the effect 
of CBT on ART adherence in 60 individuals with HIV.  Participants were randomized to receive 
CBT or standard of care (SOC).  Those in the CBT condition received individual counseling 
sessions from a psychotherapist and session content focused on participants’ life goals.  At least 
one goal was required to be related to ART adherence.  Each month, adherence data was 
collected via self-report and downloaded from a medication event monitoring system (MEMS). 
The results demonstrated a significant difference in adherence during months 10-12 of the study 
between the CBT and SOC conditions such that those in the CBT condition had higher 
adherence than those in the SOC condition.  Moreover, participants with adherence ≥ 95% was 
70% for the CBT condition and 50% for the SOC condition.  
A more recent study integrated computer technology and CBT techniques to evaluate the 
efficacy of a computer based intervention (Fisher et al., 2011).  The study took place during 
routinely scheduled visits in HIV care clinics over 18 months.  Participants were 594 adults with 
HIV, randomized to an experimental condition which required participation in an interactive 
computer-based ART adherence promotion program or standard of care (SOC).  Those in the 
experimental condition received adherence promotion strategies, selected and engaged in an 
 8 
 
activity (20 different CBT modules), and chose an adherence related goal.  Subsequent sessions 
included an update on the progress of previous goals, completing additional intervention 
activities, and selecting additional adherence related goals. Adherence was measured using the 
AIDS Clinical Trials Group (ACTG) 3-day recall measure of doses taken (Chesney, Ickovics, 
Chambers et al., 2000) and a Visual Analogue Scale (VAS) adherence assessment (Walsh, 
Mandalia, & Gazzard, 2002).  Adherence was defined as a dichotomous variable (100% vs. 
imperfect adherence).  Results indicated that participants who regularly used the computer-based 
intervention achieved significantly higher levels of adherence.  This effect was observed over 14 
visits while adherence decreased for participants in the SOC condition.        
Similar results have been found in additional studies that have evaluated the use of CBT 
to improve ART Adherence (Knobel et al., 1999; Lyon et al., 2003; Margolin et al., 2003; 
Ramirez-Garcia & Cote, 2012; Weiss et al., 2011).  However not all studies have demonstrated 
successful results (Antoni et al., 2006; Duncan et al., 2012; Funck-Brentano et al., 2005; 
Holzemer et al., 2006; Murphy et al., 2007; Tuldra et al., 2000; Wamalwa et al., 2009).  The 
discrepant findings raise concerns about whether CBT alone is sufficient to improve ART 
adherence.  
CBT and Motivational Interviewing (MI) Interventions 
Interventions using CBT techniques in conjunction with motivational interviewing (MI) 
have shown to positively impact adherence.  MI is a person-centered counseling style designed 
to strengthen motivation and commitment to change by eliciting and exploring an individual’s 
own reasons for change in an environment that include acceptance and compassion (Miller, 
2012).  This counseling style was originally created for use with individuals with substance use 
disorders and has been used with a variety of populations and behaviors including mental health 
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disorders and health-promotion behaviors in over 200 randomized trials (Miller & Rose, 2009). 
MI has been applied to ART adherence interventions through patient-centered counseling 
techniques which include eliciting participants’ adherence-related concerns, use of reflective 
listening during discussions about participants’ ideas, feelings, and ambivalence about adherence, 
discussions about importance and confidence to adhere, and providing ideas (with permission) to 
help change adherence-related behavior (Golin et al., 2006).   
Studies have found that MI in conjunction with CBT techniques have been effective to 
produce comprehensive ART adherence interventions to assist people living with HIV overcome 
difficulties with adherence (Ingersoll et al., 2011; Parsons, Golub, Rosof, & Holder, 2007; Safren 
et al., 2001).  Safren et al. (2001) evaluated the efficacy of an intervention that utilized MI, CBT, 
and problem solving therapy techniques in a randomized controlled trial consisting of 56 adults 
with HIV across 12 weeks.  Adherence was measured using an adherence questionnaire that 
asked participants about adherence during the past two weeks and was obtained from the 
participants’ daily pill diary.  Participants were randomized to a self-monitoring or life-steps 
condition.  Those in the self-monitoring condition were required to utilize a daily diary to record 
adherence.  Those in the life-steps condition participated in a single session that incorporated 11 
informational, motivational, problem-solving, and cognitive behavioral steps.  Results indicated 
improved adherence for both conditions with higher percentages of adherence for those in the 
life-steps condition.  
Similarly, Parsons, Golub, Rosof, and Holder (2007) evaluated the efficacy of an 
intervention that combined MI and CBT techniques to improve ART adherence.  Participants 
included 143 adults with HIV who also met criteria for hazardous drinking (>16 drinks per week 
for men or >12 drinks per week for women).  Participants were randomized to receive eight MI-
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CBT sessions or a time and content equivalent educational condition.  Adherence was measured 
via self-report asking participants to recall all medication doses taken and missed in the previous 
two weeks.  Drinking behavior was assessed in a similar manner by asking participants the total 
number of consumed drinks in the previous two weeks.  Data was collected at baseline, three, 
and six-month follow-up.  Results indicated that participants in both conditions reported 
significant increases in percent dose and percent day adherence between baseline and three 
months.  Additionally, participants who received the MI-CBT sessions had significantly greater 
improvement in adherence for percentage of doses and daily adherence compared to those in the 
education condition.  Improvements in adherence were maintained for both groups at six months 
and those in the intervention continued to report better adherence compared to the education only 
condition, although this difference was no longer statistically significant.  There were no 
significant differences found between conditions for alcohol use.   
Directly Observed Therapy  
Interventions aimed at improving adherence have also used external supports such as 
directly observed therapy (DOT) which require supervision during each ingested dose of a 
medication regime.  DOT has shown to be effective in improving adherence to tuberculosis (TB) 
therapy (Chaisson et al., 2001; Chaulk & Kazandijian, 1998; Chaulk & Iseman, 1997; Frieden, 
Fujiwara, Washko, & Hamburg, 1995; Curtis, Friedman, Neaigus, Jose, Goldstein, & Jarlais, 
1994) and improving ART adherence in naïve patients in controlled settings (Altice, Maru, 
Bruce, Springer, & Friedland, 2007; Babudieri, Aceti, D’Offizi, Carbonara, & Starnini, 2000; 
Fischl, Rodriguez, Scerpella, Monroig, Thompson, & Rechtine, 2000; Fontanarosa, Babudieri, 
Aceti, D’Offizi, Carbonara, & Starnini, 2000).  Fischl et al. (2000) examined prisoners enrolled 
in clinical trials who were receiving DOT or self-administered ART.  Although those receiving 
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DOT had higher viral loads and lower CD4 counts at baseline, after 48 weeks of therapy more 
patients receiving DOT had lower viral load than patients who were self-administering ART. 
Similarly, Fontanarosa et al. (2000) compared prisoners who received DOT to self-administered 
ART and found comparable results.  All patients who received DOT had a significant decrease in 
viral load after therapy, and 62% had a viral load below the detection limit compared to 34% of 
patients who self-administered ART.  Meta-analyses that have assessed the effect of DOT on 
ART adherence have revealed contradictory results.  Ford, Nachega, Engel, & Mills (2009) 
conducted a systematic review and meta-analysis of RCTs comparing DOT and self-
administered ART.  Virologic suppression at the study completion was used as the primary 
outcome measure.  They reviewed ten studies and concluded that DOT did not offer any benefit 
over self-administered treatment.  However, Hart et al. (2010) conducted a similar review and 
found differing results.  Adherence, virologic and immunologic response were used as outcome 
measures.  A review of 17 studies concluded that recipients of DOT were more likely to achieve 
an undetectable viral load, had greater increases in CD4 cell counts, and had ART adherence 
≥95% compared to recipients who self-administered ART.    
The use of DOT has demonstrated some promise in improving adherence and health 
outcomes, however cost and feasibility need to be considered.  Treatment for HIV is life long 
and can include multiple doses that need to be ingested at different times of the day.  An 
alternative to DOT called observed therapy (OT) or modified DOT (mDOT) was created as a 
solution to the issue of observing each dose.  This approach requires the supervision of ingesting 
a portion of the total doses and has been shown to be effective in a sample of patients with a 
history of adherence difficulties, incarceration, and active substance use disorder (Mitty, 
McKenzie, Stenzel, Flanigan, & Carpenter, 1999; Stenzel, McKenzie, Adelson-Mitty, & 
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Flanigan, 2000; Stenzel, McKenzie, Mitty, & Flanigan, 2001; Senak, 1997).  Mitty, McKenzie, 
Stenzel, Flanigan, and Carpenter (1999) evaluated the use of a community based mDOT for 
participants who were referred by their primary care physician because of ART nonadherence 
and/or active substance use.  Medication was initially delivered 5-7 days a week and then tapered 
to 1-3 days per week after three months.  Data was collected at baseline, one, three, and six 
months.  Results demonstrated a decrease in viral load and an increase in CD4 cell count for 
those who received mDOT at three and six months.  Lucas et al. (2006) found similar results for 
participants who received care in methadone clinics.  Participants received supervised doses of 
their ART regime on the mornings they received methadone at the clinic.  Three different groups 
of participants were compared: patients with a history of injection drug use (IDU) who received 
methadone at the time ART was used (mDOT group), patients with a history of IDU who did not 
receive methadone at the time that ART was used (the IDU-nonmethadone group), and patients 
with no history of IDU (the non-IDU group).  As found by Mitty et al. (1999), those who 
received mDOT had greater decreases in viral load and increases in CD4 cell counts compared to 
the two other groups.  These results suggest that mDOT has the potential to provide benefits for 
people living with HIV/AIDS (Goggin, Liston, & Mitty, 2007).   
The combination of MI and CBT techniques has demonstrated some promise in 
improving ART adherence, however the studies discussed thus far have used self-report 
measures of adherence.  This approach is simple and inexpensive to use, but has many 
disadvantages including recall bias (Gagné, 2005), social desirability (Farmer, 199), and over-
estimating adherence (Miller & Hays, 2000; Turner, 2002).  To overcome these disadvantages, 
researchers have used Medication Event Monitoring Systems (MEMS) in addition to self-report 
measures of adherence (DiIorio et al., 2008; Golin, Earp, Tien, Stewart, Porter, & Howie, 2006). 
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MEMS are programmed to track the date and time the pill container is opened and has been cited 
as an effective approach to measure medication intake (Claxton, Cramer, & Pierce, 2001; de 
Bruin, Hospers, van den Borne, Kok, & Prins, 2005).  Despite being more effective at measuring 
adherence than self-report, there are also biases found with this approach that may under or 
overestimate adherence due to “pocket dosing” (removing multiple pills at once for later use) or 
bottle-openings that aren’t followed by ingestion of medication (Bova, Fennie, Knafl, Dieckhaus, 
Watrous, & Williams, 2005).  In summary, the combination of MI and CBT have been found to 
be effective for improving ART adherence, however the accuracy of measuring adherence using 
self-report and MEMS is an area of concern and additional approaches to measuring adherence 
should be evaluated.  
Project MOTIV8: An Intervention that Combined MI-CBT and DOT 
 Project MOTIV8 was a novel intervention that assessed whether motivational 
interviewing-based cognitive behavioral therapy (MI-CBT) adherence counseling combined with 
modified directly observed therapy (MI-CBT/mDOT) was more effective than MI-CBT 
counseling alone or standard care (SC) in improving ART adherence and decreasing viral load. 
To date, this is the only intervention that has examined the combined effect of MI-CBT 
adherence counseling and mDOT.  This randomized controlled trial took place over 48 weeks 
and adherence was monitored using an electronic drug monitor (EDM).  
Project MOTIV8 Findings 
Mixed regression models demonstrated significant interaction effects of the intervention 
over time on non-adherence (defined as percent of doses not-taken and not-taken on time) in the 
30 days prior to each assessment. Post hoc ANOVA analyses revealed no significant group 
differences at each time point, but trends were found for better adherence at week 12 [F(1,119) = 
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3.67, p = .058] and poorer adherence at week 48 [F(1, 110) = 3.21, p = .076] for the MI-
CBT/mDOT group compared to the SC group.  The effect of group on viral load (undetectable 
compared to detectable) over time was examined using a logistic regression.  The result revealed 
no significant relationship between group and undetectable viral load (OR = .94, 95% CI = .67-
1.32, p = .72) and the odds of being undetectable significantly increased over time (OR = 1.08, 
95% CI = 1.07-1.10, p < .001).  The results of Project MOTIV8 demonstrated that the combined 
MI-CBT/mDOT intervention had its greatest impact during the most intensive component of the 
intervention (at week 12), and then indicated a steep decline as the treatment tapered and the 
study concluded (at week 24).  These results suggest that the intervention did not have any 
impact on adherence.  However, it is unclear why the intervention was ineffective.  To explain 
why Project MOTIV8 failed to demonstrate significant main effects, an assessment of the 
theoretical mediators is required.  It is important to evaluate whether the intervention was 
ineffective in impacting the theoretical mediators or the theoretical mediators were ineffective in 
impacting adherence.  
Theoretical Mediators Targeted in Project MOTIV8 
The interventions used in Project MOTIV8 were based on the Information-Motivation-
Behavioral Skills (IMB) model of behavior change (Fisher & Fisher, 1992; Fisher, Fisher, 
Misovich, Kimble, & Malloy, 1996).  This IMB model has been used to produce a 
comprehensive conceptualization of factors that impact ART adherence.  The IMB model of 
highly active ART adherence was developed to facilitate effective intervention development 
(Fisher, Amico, Fisher, & Harman, 2008).  According to this model (Figure 1), the main 
constructs of ART adherence include adherence-related information, motivation, and behavioral 
skills.  Individuals who have more adherence information, motivation, and skills for completing 
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adherence related behavior will be more likely to adhere to their ART regime.  Further, these 
main constructs work together to promote adherence behavior.  For instance, an individual who 
has information about his or her regime, is motivated to adhere, and believes that his or  
 
 
Figure 2. The Information-Motivation-Behavioral Skills model of antiretroviral therapy 
adherence information  
her family support their adherence then he or she will engage in adherence related behavioral 
skills such as self-administering medications resulting in adherence behavior.  Favorable health 
outcomes including increased CD4 cell counts and decreased viral load, are produced by the 
adherence behavior which is cycled back to influence subsequent levels of adherence 
information, motivation, and behavior skills in the future.  Numerous interventions have been 
created using the IMB model of HAART adherence (Amico et al., 2009; Goggin et al., 2013; 
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Horvath, Smolenski, & Amico, 2014; Rongkavilit et al., 2010; Starace, Massa, Amico, & Fisher, 
2006).  
Project MOTIV8 targeted the components of the IMB model using CBT, MI, and mDOT. 
CBT techniques were used to target the information and behavioral skills components of the 
IMB model.  MI was used to target the motivation component, and mDOT was used to target 
skills for adherence with the use of prompts and repeated practice.  Knowledge, motivation, and 
skills for adherence were discussed in 10 counseling sessions.   Although the intervention was 
developed to affect numerous IMB based mediating variables, the results suggested that either 
the MI-CBT and mDOT components of the intervention were ineffective at impacting the IMB 
based mediating variables or the mediating variables did not impact adherence.  Much can be 
learned by exploring these possibilities in studies like MOTIV8 that fail to find main effects.  
Examining the mediators is critical to understanding why interventions do and do not work 
which contribute to the advancement of treatment and adherence treatment research (Kraemer et 
al., 2002).  The present study examined the role of IMB based mediator variables in Project 
MOTIV8 by assessing the impact of MI-CBT/mDOT relative to MI-CBT and SC on IMB based 
mediator variables as well as the relationship between changes in mediator variables and 
adherence. 
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CHAPTER 3 
METHODOLOGY 
 The data for this secondary analysis came from Project MOTIV8, a five year, three-
armed, multi-site randomized controlled trial.  The primary aim of this project was to assess 
whether motivational interviewing based cognitive behavioral therapy counseling with modified 
directly observed therapy (MI-CBT/mDOT) was more effective than motivational interviewing 
based cognitive behavioral therapy counseling alone (MI-CBT) or standard care (SC) for 
increasing ART adherence among 204 HIV-positive community clinic patients (Goggin et al., 
2013).  
Procedure 
 Data were collected at six outpatient clinics in Kansas City from December 2004 to 
August 2009.  To be eligible to participate in the study, participants had to be HIV-positive and 
were starting ART for the first time, making a change in their regimen, or reported having 
adherence problems (which was confirmed by provider documentation).  Eligible participants 
were also 18 years of age or older, spoke English and lived within a 70-mile radius of the project 
office.  Participants were excluded if they did not self-administer their ART, were pregnant, or 
had an acute medical condition that would interfere with their participation in the study.  All 
study procedures were approved by the appropriate Institutional Review Boards.  
 Participants completed baseline assessments that included demographic, adherence, and 
psychosocial variables using the Audio Computer Assisted Self Interview.  Group randomization 
was stratified by clinic and ART naïve/experienced.  Participants were given an electronic drug 
monitor (EDM; http://www.aardex.ch) to monitor adherence throughout the course of the study.  
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Data used for this analysis are from baseline, 24, and 48 weeks of the study, because data on 
mediator variables were collected at each of those time points.  
Intervention 
Motivational Interviewing Based Cognitive Behavioral Counseling (MI-CBT) 
 Participants assigned to the MI-CBT and MI-CBT/mDOT groups received care as usual 
from their clinic providers, six MI-CBT counseling sessions in person, and four telephone 
sessions with project staff members.  The MI-CBT intervention included the use of MI 
techniques to increase motivation and confidence for change. Additionally, CBT approaches 
were used in an MI-consistent style to enhance knowledge and build skills for adherence during 
six face-to-face counseling sessions (weeks 0, 1, 2, 6, 11, and 23) and four telephone sessions 
(weeks 4, 9, 15, and 19).  Counseling was conducted in 10 sessions and consisted of 11 different 
treatment modules (See Table 1).  The first two sessions included enhancing motivation and 
confidence, and the self-monitoring modules, respectively. The patient was then given the 
opportunity to choose which module to discuss during the counseling session during the next 
seven sessions, and the last session included information on the relapse prevention module.   
Modified Directly Observed Therapy (mDOT) 
 Participants in the MI-CBT/mDOT group received the same care as those in the MI-CBT 
group, but also received daily visits (Monday through Friday) from project staff to observe 
ingestion of an ART dose.  For participants with multiple doses, only ingestion of one dose was 
observed.  Each visit took place at a location and time that was most convenient for the 
participant.  Daily visits occurred between baseline and week 16 of the study and were tapered 
between weeks 17 through 24, and ceased at week 24.  Changes in medication regimes 
prescribed, late night dosing, and the inclusion of participants who lived outside the catchment 
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area led to revision of the mDOT protocol over the course of the study to include in person as 
well as ‘phone contacts’ (participant ingested medication during a study staff initiated phone call 
at the predetermined dose time), ‘med delivery’ (medications delivered outside of target dosing 
time and participant reported by phone/text when ingested), and PDA visits (medications 
delivered outside of target dosing time and participant retrospectively reported on all unobserved 
doses using personal digital assistant). 
Therapists and Fidelity 
Counselors were Master’s degree level professionals, were trained in MI and supervised 
by a licensed clinical psychologist.  All sessions were digitally recorded and received ongoing 
weekly supervision.  To determine fidelity throughout the study, session tapes were randomly 
selected during supervision and coded using a 26-item coding scheme adapted from a prior study 
(Harris, Catley, Good, et al., 2010).  Counselors achieved high fidelity throughout the course of 
the study with an average rating of 6.2 (SD = 1) on an overall summary item (“Overall, how well 
did the counselor conduct this session?”) scored on a 7-point scale ranging from poor to 
excellent (1-7). 
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Table 1. Project MOTIV8 Counseling Treatment Modules  
Session 
1 
Enhancing motivation and confidence – Assess importance and 
confidence to adhere, discuss the positives and negatives of adherence, 
discuss the relationship between values and health  
2 Self-monitoring – Discuss factors that facilitate and hinder patient’s 
adherence 
 
Patient 
Chooses  
 
Session 
3-9 
Goal setting – Review values and discuss relationship between 
adherence and values, elicit patient’s reasons for taking medications, 
complete goal setting worksheet for treatment (patient creates a 
specific, realistic goal to complete for the week and determines 
methods to achieve goal) 
Problem solving – Discuss barriers to adherence and possible 
solutions to barriers; with permission, counselor suggests other 
solutions to barriers; patient determines best solution and actions to 
carry out solution 
Adherence aids and stimulus control – Engage patient in 
brainstorming ways to remind him/herself to take medications; 
determine which strategy is most helpful and discuss past examples of 
success; with permission, counselor suggests other strategies and tools 
that could be helpful in prompting to take medications on time 
Thought stopping – Counselor discusses specific strategy to counter 
negative thoughts (e.g., thoughts about undesirable side-effects of 
medications, pessimism about future of one’s health) about taking 
medications 
Personal support – Patient identifies people in their lives who can be 
a source of support in treatment and how they could be helpful; with 
permission, discuss the difficulty of discussing HIV treatment with 
others 
Symptom management – Discuss symptoms and side-effects of 
medications; introduce symptom management skills (discussing with 
doctor, discuss factors that may decrease or increase symptoms, elicit 
other ideas from patient to try) 
Medication refill skills – Discuss steps to ensure medications are 
available; with permission, provide suggestions to have medications 
available 
Talking to your doctor – Explore previous communication with 
doctor; review pro and cons of discussing important topics with 
doctor; elicit other treatment concerns patient can discuss with their 
doctor; with permission, role-play the doctor interaction with the 
patient 
 
Session 
10 
Relapse prevention – Discuss current and future barriers to 
adherence; elicit strategies for dealing with obstacles; discuss patient’s 
experience and progress in the program; review strategies that have 
been most helpful in adhering to treatment 
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Measures 
Baseline Measures 
 Demographic measures included age, race, gender, sexual orientation, education, income, 
housing status, relationship status, and number of children.  Data were collected on alcohol and 
drug use, depression, and perceived stress.  Clinically related baseline measures included CD4 
cell count (< 200), viral load copies (>100,000), having a protease inhibitor-based regimen, and 
starting ART for the first time.  Study staff abstracted these data from participants’ medical 
records.   
Mediator Variables 
Mediator variables included 14 observed variables that contributed to the three (IMB) 
constructs. The observed variables are listed under their hypothesized constructs below. 
Information related variables were measured using two different questionnaires.  
Knowledge About ART 
 The first measure was a 12-item inventory of true/false/don’t know items, developed to 
assess patients’ knowledge of combination therapy, the concept of drug resistance, and the 
consequences of non-adherence (Wagner, Kanouse, Koegel, & Sullivan, 2004).  Higher scores 
indicate higher levels of ART knowledge.  
ART Medical Knowledge 
 A second scale was developed by project staff to provide a measure of the participant’s 
knowledge of adherence to their ART medications. There is one general question that was 
answered by all participants: How perfectly do you think you need to stick to your medication 
schedule for you to minimize the chance of developing resistance to your HIV medications?  
Please give your answer as a number between 0 and 100 where 0 means that you do not need to 
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stick to your schedule at all (for instance, you can skip all doses or never take any doses on time), 
and 100 means that you need to stick perfectly to your schedule (for instance, you take all doses 
on time). The remaining questions asked participants about timing and time windows for their 
medication schedules. Higher percentage correct signifies greater levels of ART medication 
adherence knowledge.     
 Motivation related variables were measured using five different scales.   
Motivation to Adhere 
 A 5-item self-report scale was developed for the project to assess participant’s level of 
readiness to adhere.  Items tapped “desire”, “reasons”, “need”, and “commitment” to adhere and 
were developed based on the motivational constructs defined by Amrhein, Miller, Yahne, Palmer, 
and Fulcher (2003) and were rated on a scale from 0 (not ready at all) to 10 (absolutely ready). 
Higher scores indicate greater levels of motivation to adhere.  
Autonomous and Controlled Motivation 
 The Treatment Self-Regulation Questionnaire (TSRQ) was used to measure autonomous 
motivation.  Based on the Self-determination theory, this 12-item scale measured the extent to 
which participants engaged in specific health behaviors of their own volition because such 
behaviors held personal importance for them, rather than doing so as a response to external 
pressures.  Two different subscales are included in this measure: autonomous motivation and 
controlled motivation. Items were modified to address ART adherence and were rated on a scale 
from 1 (strongly disagree) to 7 (strongly agree).  Higher scores reflect greater levels of adherence 
because of autonomy or control from external pressures.  An example for an autonomy item is: 
The reason I would take my HIV medications as they were prescribed to me is because I feel that 
I want to take responsibility for my own health. An example item for control is: The reason I 
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would take my HIV medications as they were prescribed to me is because I feel pressure from 
others to do so.  
Autonomy Support From Providers 
 The Health Care Climate Questionnaire (HCCQ) was used to measure support for patient 
autonomy surrounding HIV medications from health care providers.  The 6-item questionnaire 
based on principles of the Self-determination theory was modified for the purpose of this study 
to address adherence to HIV medications.  Items were rated on a scale from 1 (strongly disagree) 
to 7 (strongly agree).  Higher scores signify greater levels of support from providers.  Example 
items include: My health-care providers have provided me with choices and options about my 
HIV treatment (including not participating in treatment). My health-care providers understand 
how I see things with respect to my HIV treatment. My health-care providers convey confidence 
in my ability to participate in HIV treatment.  
Necessity and Concern for Adherence  
 Participants’ beliefs about the personal benefits and costs of their ART regime were 
measured using a 10-item scale (Horne, Weinman, & Hankins, 1999).  This measure includes 
two subscales: necessity and concern. Items were rated on a scale from 1 (strongly disagree) to 5 
(strongly agree). Higher scores signify greater levels of necessity and concern for adherence. An 
example item from the necessity subscale is: Without my medicines I would be very ill. An 
example item from the concern subscale is: Having to take medicines worries me. 
Social Support  
 Perceived social support for adherence was measured using a 4-item scale to assess 
participants’ perceived social support for adherence in the last 30 days (Simoni, Frick, Lockhart, 
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& Liebovitz, 2002). Four items queried the number of people available from 0 (no one) to 3 
(many). Higher scores signify greater amounts of social support for adherence. 
 Behavioral skill related variables were measured using three different measures.  
Self-efficacy for Adherence 
 Participants’ self-efficacy to adhere was measured using a 10-item self-report scale 
developed to assess level of confidence in performing specific medical management tasks 
(Chesney et al., 2000). Items were rated on a scale from 0 (cannot do at all) to 10 (certain I can 
do). Higher scores indicate greater levels of self-efficacy for adherence. 
Patient, Logistical, and Medication Related Reasons for Nonadherence 
 Reasons for non-adherence were measured using an 18-item scale adapted from the Adult 
AIDS Clinical Trials Group (AACTG) measures (Chesney et al., 2000).  The scale included a 
variety of reasons participants may have missed taking their medications and consisted of three 
different subscales: patient issues, logistics, and medication related.  Items were rated on a scale 
from 0 (never) to 3 (often).  Higher scores signified greater levels of non-adherence.  Example 
items for patient, logistic, and medication issues include: you were away from, you didn’t have 
transportation to get a prescription or go to the pharmacy, you had too many pills to take 
respectively.  
Perceived Difficulty of Regime 
 Participants’ difficulty of current medication regime was measured using a 7-item scale 
developed to assess perceived difficulty of regime when participants thought about number of 
pills, side effects of medications, and the overall difficulty (Kennedy, Goggin, & Nollen, 2004).  
Items were rated on a scale from 1 (not at all difficult) to 5 (extremely difficult). Higher scores 
signify greater perceived difficulty of medication regime. 
 25 
 
Outcome Variable 
Adherence 
Antiretroviral therapy adherence (≥ 90%) was measured using medication bottle caps that 
recorded the date and time of each opening.  Data were downloaded monthly and summary 
scores were calculated for each participant to track adherence throughout the course of the study.  
For the purposes of this study, adherence was measured as a dichotomous variable of 90% or 
greater adherence to all doses during the 30 day period before each evaluation visit (24 and 48 
weeks).  The 90% adherence cutoff point was used because it was determined to be the most 
clinically relevant to prevent disease progression, transmission, and suppress viral load (Gifford 
et al., 2000; Harrigan et al., 2005; Moore, Keruly, Gebo, & Lucas, 2005; Department of Health 
and Human Services, 2008).  
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CHAPTER 4 
ANALYSES 
Preliminary Analyses 
Prior to testing the mediation model, descriptive statistics were used to describe sample 
characteristics (i.e., age, ethnicity, education level, SES, etc.).  A one-way analysis of variance 
(ANOVA) was used to determine any group differences in baseline variables between the three 
intervention groups. To determine the best represented constructs for use in our mediation model, 
an initial analysis was conducted to test the measurement invariance for each latent construct. A 
principal components analysis (PCA) was used to reduce the number of mediator variables that 
represented the constructs in the IMB model. The analysis included the total scale scores for each 
measure to extract latent constructs to determine an initial structure for investigation.  
Prior to conducting the PCA, appropriateness of the data was assessed using the Kaiser-
Meyer-Olkin Measure of Sampling Adequacy (KMO) statistic, an anti-image correlation matrix, 
and Bartlett’s Test of Sphericity. Specific distributional assumptions were not required for data 
reduction purposes because conducting a principal components analysis makes no distributional 
assumptions and normal distributions are not required (Linting, Meulman, Groenen, & Van der 
Kooij, 2007). The value of the KMO statistic was used to examine appropriateness of the data for 
factor analysis. Values less than 0.50 are considered unacceptable and indicate that the data are 
not appropriate for factor analysis (Kaiser, 1974). Values between 0.50 and 0.70 are considered 
mediocre, values between 0.70 and 0.80 are good, values between 0.80 and 0.90 are great, and 
values greater than 0.90 are superb (Hutcheson & Sofroniou, 1999). If the value of the KMO 
statistic was less than 0.50, we examined the Anti-Image Correlation Matrix.  
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Diagonal values of the Anti-image Correlation Matrix are produced by the KMO statistic 
and indicate which variables should be considered for removal (Field, 2013). Any variable with a 
value less than 0.50 was removed from the analysis. Bartlett’s Test of Sphericity was used to 
ensure that there are correlations in the data that indicate that the data were appropriate for factor 
analysis. This test generated an intercorrelation matrix which calculate the collinearity of the 
variables. If the intercorrelation matrix is an identity matrix (the correlation of every variable 
with itself is equal to one and the off-diagonal values are all equal to zero), this would indicate 
that there was no collinearity among the variables and the data would not be appropriate for 
factor analysis. A significant value (p < 0.05) for the Bartlett’s Test of Sphericity indicate that 
the intercorrelation matrix is not an identity matrix and that the data are appropriate for factor 
analysis (Field, 2013). Once the KMO statistic is greater than 0.50 and the value of the Bartlett’s 
Test of Sphericity is significant, the data can be used for factor analysis.  
A Principle Component Analysis (PCA) with Promax rotation was used as the extraction 
method because the IMB constructs were expected to correlate (Gorsuch, 1983). Latent 
constructs were determined by examining the loadings in the Component Matrix. Observed 
variables that have adequate (0.50 or better) loadings and no cross-loadings between components 
in the Component Matrix were retained and considered for each latent construct. Variables that 
loaded on more than one component were examined individually. In general, they were retained 
on the component where they evidence the highest loading, but conceptual considerations of 
their fit with the other items in a component were also taken into consideration by examining the 
content of each item. Variables that did not load well (< 0.40) on any component were 
considered for removal or retained individually in the models if there were no other variables to 
represent the constructs of the IMB model. Common themes and latent constructs were identified 
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by examining the variables that loaded on these components. The number of latent constructs 
were determined by examining the number of components with eigenvalues greater than 1 in the 
scree plot, construct validity of each component, and the variance explained by each component.      
Once the number of latent constructs were determined, a confirmatory factor analysis 
(CFA) was conducted using Mplus version 6.11 for each latent construct.  A CFA was used to 
examine measurement invariance to demonstrate that the psychometric properties of the 
observed variables were generalizable over time (e.g. the same constructs are being measured 
over time; Horn & McArdle, 1992; Meredith, 1993).  Measurement invariance can be established 
by conducting a series of tests.   
The first test was to conduct an omnibus test of equality to assess if the covariance 
matrices and mean structures are equal across time points.  If the matrices did not differ between 
time points, this provided support for invariance and there was no need to proceed with further 
invariance testing.  If the matrices differed, additional testing was required starting with an 
unconstrained model progressing to more restricted models until the most appropriate level of 
invariance has been identified (Little, Preacher, Selig, & Card, 2007).  The paths of the retained 
variables were specified to load onto their respective latent constructs (e.g., motivation related 
variables were specified to load onto adherence motivation; Bandalos, 1997; Kline, 2005) and 
error from the same variables were correlated across time (See Figure 3).  Equality constraints 
were applied to identify the level of invariance which include configural, metric, scalar, and 
residual. 
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Figure 3. Testing invariance of adherence motivation over time 
To identify the most appropriate level of invariance, model fit was examined using Chi-
Square (X
2
), relative X
2
 (X
2
/df), root mean square error of approximation (RMSEA), comparative 
fit index (CFI; Bentler, 1990), and standardized root mean square residual (SRMR).  The X
2
 
value (also known as the discrepancy function, likelihood ratio chi-square, or chi-square 
goodness of fit) is a measure to assess overall model fit to determine whether the model fits the 
data well.  A model with good fit would produce an insignificant X
2 
value (p > 0.05; Kline, 2005).  
However sample sizes greater than 200 are likely to produce a larger X
2 
value that is more likely 
to be significant erroneously suggesting poor model fit (Schumaker & Lomax, 2004; Tanaka, 
1993).  Additionally, the X
2 
value is also affected by model size (value increases with more 
variables included in a model) and the distribution of the variables (value increases with highly 
skewed and kurtotic variables).  The relative X
2
 value is less sensitive to sample size but 
encompasses similar problems of the X
2 
test.  Moreover, it is unclear what value would indicate 
acceptable model fit.  Researchers have recommended values as low as two (Byrne, 1998; 
Tabachnick & Fidell, 2001) and as high as five to indicate reasonable fit (Marsh & Hocevar, 
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1985).  Although the X
2 
and relative X
2 
tests have severe limitations, they continue to be 
commonly reported fit statistics (Hooper, Coughlan, & Mullen, 2008).   
Alternative indices were also used to assess model fit that are not sensitive to sample size 
and do not assume multivariate normality.  The RMSEA is a measure of lack of fit, where values 
below 0.08 indicate acceptable fit and below 0.05 indicate excellent fit (Hu & Bentler, 1995).  
The RMSEA has been referred to as ‘one of the most informative fit indices’ (Diamantopoulos & 
Siguaw, 2000) because of its sensitivity to the number of estimated parameters in the model.  
The RMSEA will select the most parsimonious model, that is, the one with the fewest number of 
parameters (Hooper, Coughlan, & Mullen, 2008).  Further, another advantage of the RMSEA is 
that it produces a confidence interval around its value (MacCallum et al., 1996) based on the 
known distribution values of the statistic which allows the null hypothesis (poor fit) to be tested 
more precisely (McQuitty, 2004).   
Comparative fit index values above 0.90 or 0.95 indicate acceptable and excellent fit, 
respectively.  The CFI takes into account sample size (Byrne, 1998) and produces a model fit 
estimate that performs well even when the sample size is small (Tabachnick & Fidell, 2001).  
This index is included in all SEM programs and is one of the most commonly reported fit indices 
because it is one of the measures that is least affected by sample size (Fan et al, 1999).  The 
SRMR is an absolute measure of fit and values less than .08 are considered to represent good fit 
(Hu & Bentler, 1999).  It is the square root of the difference between the residuals of the sample 
covariance matrix and the hypothesized covariance model and is more meaningful and easier to 
interpret than the root mean square residual (RMR; Hooper, Coughlan, & Mullen, 2008). 
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Primary Analyses 
  Once invariance and adequate model fit were determined, a multilevel, multiple 
mediation design was used to determine the indirect effects on adherence through the invariant 
latent constructs found in the preliminary analysis.  Following the recommendation of Preacher, 
Zhang, and Zyphur, (2010), mediation was assessed using a multilevel mediation model because 
the data are clustered at the group level.  If data were analyzed at the individual level and 
clustering for each intervention group (MI-CBT/mDOT, MI-CBT, or SC) were ignored, an 
inflation of type I error may occur (Krull & MacKinnon, 1999; 2001).  Moreover, it may be 
possible that the mechanism that mediates effects at the group level is different from the 
mechanism that mediates effects at the individual level.   
In Project MOTIV8, the intervention was assessed at the group level and the mediators 
and adherence were assessed at the individual level. As such, a 2-1-1 design was used to assess 
mediation.  Additionally, as recommended by Preacher and Hayes (2008), multiple mediators 
were examined simultaneously.  Advantages to specifying and testing a single multiple 
mediation model compared to separate simple mediation models include the: possibility to 
determine the extent to which specific variables mediate the relationship between independent 
and outcome variables, reduced likelihood of parameter bias, and ability to determine the 
magnitude of specific indirect effects associated with all mediators.  
 Specific indirect effects of intervention group on adherence were calculated using the 
product-of-coefficients approach also called the Sobel test (Sobel, 1982, 1986).  The formula for 
specific indirect effects in a multiple mediator model is the same as the formula used in single-
mediator models (Preacher & Hayes, 2008).  For example, the indirect effect of group on 
adherence through a mediator is calculated by the product (ab) of the unstandardized paths 
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linking group to the mediator (a) and mediator to adherence (b).  The total indirect effect of 
group on adherence is the sum of the specific indirect effects, Σi(aibi), i =1 to 3 (See Figure 4).  
 
 
Figure 4. Illustration of a multiple mediation design with three mediators  
 Following the recommendations of Hayes and Preacher (2013), indicator coding was 
used to dummy code the three intervention groups to represent comparisons of interest to allow 
for simultaneous hypothesis testing.  The three levels were transformed into two variables: 
Contrast 1 and Contrast 2. Contrast 1 compared the two treatment conditions with SC.  MI-CBT 
and MI-CBT/mDOT were given values of 0.33 and SC was given a value of -0.67.  Contrast 2 
compared MI-CBT/mDOT and MI-CBT by assigning the value of 0.5 and -0.5, respectively. 
Indirect effects were assessed by calculating the product (ab) of the unstandardized paths linking 
each contrast code to the mediator (a) and mediator to adherence (b).  The total indirect effect of 
group on adherence is the sum of the specific indirect effects, Σi(aibi), i =1 to 3 (See Figure 5).  
Mplus was used to calculate the variance, standard error, and odds ratios to determine statistical 
significance.  Significant indirect effects indicated which mediators were impacted by treatment 
and which mediators impacted adherence.   
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Figure 5. Mediation model examining Information Motivation Behavior Skills constructs as 
mediators between condition and adherence 
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CHAPTER 5 
RESULTS 
Preliminary Analyses 
To describe sample characteristics, descriptive statistics for demographic and IMB based 
mediator variables were assessed.  Demographic characteristics (n = 204) are shown in Table 2. 
Participant ages ranged from 18-65 (M = 40.37, SD = 9.56).  Seventy-six percent (n = 155) 
identified their gender as male at birth.  The majority of the participants identified themselves as 
African American (57%) or white (31%).  The education of participants varied widely; about 
22.5% (n = 46) did not have a high school degree, 30% (n = 62, 60) of participants had obtained 
a high school degree/GED or some college training, about 9% (n = 18) had a college degree, and 
a little less than 2% (n = 3) had a graduate degree.  
Table 2. Characteristics of Study Participants  
Variable Study Participants (n = 204)  
 n(%) 
Gender  
 Female 49(24) 
 Male 155(76) 
Race  
 African American 116(56.9) 
 White 64(31.4) 
 Hispanic or Latino 19(9.3) 
 American Indian/Alaskan Native 5(2.5) 
 More than 1 race 14(6.9) 
Education  
 < High School 46(22.5) 
 High School/GED 62(30.4) 
 College Degree 18(8.8) 
 Graduate Degree 3(1.5) 
Estimated Monthly Income  
 0-1000 125(61.2) 
 1001-2000 36(17.6) 
 2001-3000 15(7.4) 
 > 3000 9(4.4) 
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Overall, participants were highly motivated to adhere, had high levels of self-efficacy for 
adherence, and reported they were most likely to not adhere because of patient related factors 
(e.g., being away from home).  Descriptive statistics for mediator variables are shown in Table 3.  
Table 3. Descriptive Statistics for Mediator Variables 
Mediator Variable Baseline 
M (SD) 
24 weeks 
M (SD) 
48 weeks 
M (SD) 
Information related variables    
Knowledge about ART 8.89 (1.86) 9.39 (1.77) 9.28 (1.96) 
ART medical knowledge .190 (.12) .201 (.12) .204 (.13) 
Motivation related variables    
Motivation to adhere 9.34 (1.08) 9.29 (1.35) 9.46 (1.09) 
Autonomous motivation 6.71 (.55) 6.66 (.81) 6.69 (.74) 
Controlled motivation 4.43 (1.63) 4.48 (1.66) 4.62 (1.69) 
Autonomy support from providers 6.46 (.78) 6.52 (.89) 6.55 (.90) 
Necessity for adherence 3.99 (.74) 4.01 (.82) 4.10 (.78) 
Concern for adherence 2.82 (.82) 2.41 (.79) 2.38 (.89) 
Social support for adherence 1.69 (.74) 1.57 (.89) 1.53 (.88) 
Behavioral skill related variables     
Self-efficacy to adhere 8.20 (1.6) 8.38 (1.69) 8.87 (1.39) 
Patient related reasons for nonadherence 4.54 (5.14) - 3.45 (3.95) 
Logistical related reasons for nonadherence 1.35 (2.51) - 1.02 (2.19) 
Medication related reasons for nonadherence 3.86 (4.99) - 2.11 (3.86) 
Perceived difficulty of regime 1.70 (.76) 1.42 (.63) 1.40 (.68) 
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A one-way analysis of variance (ANOVA) was conducted to determine whether there were 
significant group differences in baseline mediator variables between the three intervention 
groups.  Results revealed no significant differences between the groups (see Table 4).  
Table 4. One-way ANOVA Examining Group Differences in Baseline Mediator Variables 
Mediator Variable Df F 2 p 
Information related variables     
Knowledge about ART 2 1.55 .03 .22 
ART medical knowledge 2 2.65 .05 .08 
Motivation related variables     
Motivation to adhere 2 1.23 .02 .29 
Autonomous motivation 2 .05 .00 .95 
Controlled motivation 2 .16 .00 .85 
Autonomy support from providers 2 .20 .00 .82 
Necessity for adherence 2 .26 .01 .78 
Concern for adherence  2 .19 .00 .83 
Social support for adherence 2 .99 .02 .38 
Behavioral skill related variables     
Self-efficacy to adhere 2 .50 .01 .61 
Patient reasons for nonadherence 2 .95 .02 .39 
Logistic reasons for nonadherence  2 .56 .01 .57 
Medication reasons for nonadherence 2 2.41 .05 .09 
Perceived difficulty of regime 2 .65 .01 .53 
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 Prior to the main analysis, a PCA was used as a data reduction technique to extract latent 
constructs from 14 observed variables. Latent constructs were identified by examining the 
variables that loaded to the components. Hypothesized constructs and variables are presented in 
Table 5.     
 
Table 5. Observed Variables Assessed in PCA 
Information related variables  
1. Knowledge about ART 
2. ART medical knowledge 
Motivation related variables 
3. Motivation to adhere 
4. Autonomous motivation 
5. Controlled motivation 
6. Autonomy support from providers 
7. Necessity for adherence 
8. Concern for adherence 
9. Social support 
Behavioral skill related variables 
10. Self-efficacy to adhere 
11. Patient related reasons for nonadherence 
12. Logistical related reasons for nonadherence 
13. Medication related reasons for nonadherence 
14. Perceived difficulty of regime 
 
 Prior to conducting the PCA to identify latent constructs, appropriateness of the data was 
assessed using the Kaiser-Meyer-Olkin Measure of Sampling Adequacy (KMO) statistic and 
Bartlett’s Test of Sphericity.  The KMO statistic was above the recommended value of 0.50 and 
Bartlett’s Test of Sphericity was significant for each time point of the study indicating that 
correlations in the data were appropriate for conducting factor analyses (see Table 6).  Given 
these overall indicators, all mediator variables were retained and used to conduct factor analyses.  
 
 38 
 
Table 6. KMO Statistic and Bartlett’s Test of Sphericity at Each Time Point 
Time KMO Statistic Df X
2
 p 
Baseline .74 91 813.34 <.001 
Week 24 .81 55 601.43 <.001 
Week 48 .75 91 662.80 < .001 
 
A PCA with Promax rotation was used as the extraction method for data collected at 
baseline, week 24, and week 48.  Latent constructs were determined by examining the 
eigenvalues in the scree plot, the variance explained by each factor, the factor loadings, and 
construct validity. 
Factor Structure for Baseline Data 
 There were four factors that had eigenvalues ≥ 1. The first factor explained 25% of the 
variance, the second factor explained 16% of the variance, and a third factor explained 11% of 
the variance.  The fourth component had an eigenvalue equal to 1 and explained 7% of the 
variance. The four factor solution which explained 59% of the variance was retained because of 
previous theoretical support, sufficient number of primary loadings (> 0.50), the “leveling off” of 
factors with eigenvalues > 1 in the scree plot, and ease of interpreting the fourth factor.  One 
variable (amount of perceived social support) was eliminated because it failed to meet the 
minimum criteria of having a primary factor loading ≥ 0.40.  The Information, Motivation, and 
Behavioral Skills constructs from the IMB model were identified, and a fourth factor which 
encompassed concerns about adherence and perceived difficulty of regime was also identified.  
Two observed variables (knowledge about ART and ART medication knowledge) composed the 
information factor.  Five observed variables (motivation to adhere, autonomous motivation, self-
efficacy to adhere, autonomy support from providers, and necessity for adherence) composed the 
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motivation factor.  Three observed variables (patient reasons, medication related, and logistic 
reasons for nonadherence) composed the behavioral skills factor.  Lastly, three observed 
variables (concern for adherence, perceived difficulty of adherence, and control motivation) 
composed the fourth factor.    
To determine changes in the factor structure after removing the amount of perceived 
social support, a PCA of the remaining 13 mediator variables using Promax rotation was 
conducted. There were no changes in the factor structure as four factors had eigenvalues ≥ 1 and 
the same observed variables composed each of the four factors. The amount of variance 
explained by the four factor structure explained 62% of the variance. All variables had loadings 
> 0.50 and only two variables had a cross-loading > 0.40 (beliefs related to the necessity of ART, 
perceived difficulty of regime), however these two variables had a primary loading of 0.52 and 
0.58, respectively, and were retained on their primary factors. The factor loading matrix for the 
final solution of baseline mediator variables is shown in Table 7. 
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Table 7. Factor loadings based on a PCA with Promax Rotation for 13 baseline mediator 
variables 
 
ART 
Information 
Adherence 
Motivation 
Adherence 
Behavioral 
Skills 
Negative 
Adherence 
Beliefs  
Knowledge about ART .79    
ART medication knowledge .78    
Motivation to adhere  .78   
Autonomous motivation  .76   
Self-efficacy to adhere  .71   
Autonomy support from providers  .64   
Necessity for adherence   .52   
Patient reasons for nonadherence   .93  
Medication reasons for nonadherence   .91  
Logistical reasons for nonadherence   .78  
Concerns for adherence    .81 
Perceived difficulty of regime    .58 
Controlled motivation    .52 
 
 
Factor Structure for Week 24 Data 
 There were three factors that had eigenvalues ≥ 1. The first factor explained 34% of the 
variance, the second factor explained 12% of the variance, and a third factor explained 11% of 
the variance.  The three factor solution which explained 57% of the variance was retained over a 
four factor solution because of previous theoretical support, sufficient number of primary 
loadings (> 0.50), and the “leveling off” of the number of factors with eigenvalues greater than 1 
in the scree plot. Similarly to the results of the PCA found using baseline data, amount of 
perceived social support was eliminated.  This observed variable did not belong conceptually 
with the information factor and had a weak primary loading (0.45).  Three variables (patient, 
medication related, and logistic reasons for nonadherence) were not measured at this time point 
and were not included in the PCA.  The information, motivation, and behavioral skills constructs 
from the IMB mode were identified.  Two observed variables (knowledge about ART and ART 
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medication knowledge) composed the information factor.  Six observed variables (motivation to 
adhere, autonomous motivation, self-efficacy to adhere, autonomy support from providers, 
perceived difficulty of regime, and concern for adherence) composed the motivation factor.  Two 
observed variables (control motivation and necessity for adherence) composed the behavioral 
skills factor.  
To determine changes in the factor structure after removing the amount of perceived 
social support, a PCA of the remaining 10 mediator variables using Promax rotation was 
conducted.  There were three factors that had eigenvalues ≥ 1 and all observed variables loaded 
on the same factors except for concern for adherence which had a weak loading (0.47) on the 
behavioral skills factor.  The three factor solution explained 67% of the variance.  There were no 
cross-loadings > 0.40.  The factor loading matrix for the final solution of week 24 mediator 
variables is shown in Table 8. 
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Table 8. Factor loadings based on a PCA with Promax Rotation for 10 mediator variables at 
Week 24 
 
ART 
Information 
Adherence 
Motivation 
Adherence 
Behavioral 
Skills 
Negative 
Adherence 
Beliefs  
Knowledge about ART .77    
ART medication knowledge .75    
Motivation to adhere  .90   
Autonomous motivation  .81   
Self-efficacy to adhere  .85   
Autonomy support from providers  .77   
Necessity for adherence     .53 
Patient reasons for nonadherence     
Medication reasons for nonadherence     
Logistical reasons for nonadherence     
Concerns for adherence    .47 
Perceived difficulty of regime  -.66   
Controlled motivation    .74 
 
 
Factor Structure for Week 48 Data 
 There were four factors that had eigenvalues ≥ 1. The first factor explained 27% of the 
variance, the second factor explained 15% of the variance, and a third and fourth factor 
explained 9% of the variance. The three factor solution which explained 52% of the variance was 
retained because of previous theoretical support, sufficient number of primary loadings (> 0.50), 
the “leveling off” of factors with eigenvalues greater than 1 in the scree plot, and difficulty 
interpreting the fourth factor. Similarly to the results of the PCA found using baseline and week 
24 data, amount of perceived social support was eliminated. This observed variable failed to 
meet the criteria of fitting conceptually with the factor on which loaded. The information, 
motivation, and behavioral skills constructs from the IMB mode were identified. Two observed 
variables (ART medication knowledge and perceived difficulty of regime) composed the 
information factor. Five observed variables (motivation to adhere, autonomous motivation, self-
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efficacy to adhere, autonomy support from providers, and necessity for adherence) composed the 
motivation factor. Five observed variables (medication reasons for nonadherence, patient reasons 
for nonadherence, logistic reasons for nonadherence, control motivation, and knowledge about 
ART) composed the behavioral skills factor.  
To determine changes in the factor structure after removing the amount of perceived 
social support, a PCA of the remaining 13 mediator variables using Promax rotation was 
conducted. There were three factors that had eigenvalues ≥ 1 and all observed variables loaded 
on the same factors except for control motivation which had a weak loading (0.33) to the 
motivation factor and was eliminated. To determine changes in the factor structure after 
removing control motivation, a PCA of the remaining 12 mediator variables using Promax 
rotation was conducted. There were three factors that had eigenvalues ≥ 1 and all observed 
variables loaded on the same factors. A three factor solution explained 59% of the variance. All 
observed variables had loadings > 0.50 and only two variables had a cross-loading > 0.40 (self-
efficacy for adherence and perceived difficulty of regime), however these two variables had a 
primary loading of 0.77 and 0.65, respectively, and were retained on their primary components. 
The factor loading matrix for the final solution of week 48 mediator variables is shown in Table 
9. 
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Table 9. Factor loadings based on a PCA with Promax Rotation for 12 mediator variables at 
Week 48 
 
ART 
Information 
Adherence 
Motivation 
Adherence 
Behavioral 
Skills 
Negative 
Adherence 
Beliefs  
Knowledge about ART   -.54  
ART medication knowledge .75    
Motivation to adhere  .85   
Autonomous motivation  .77   
Self-efficacy to adhere  .75   
Autonomy support from providers  .64   
Necessity for adherence   .51   
Patient reasons for nonadherence   .79  
Medication reasons for nonadherence   .88  
Logistical reasons for nonadherence       .73     
Concerns for adherence   .64                        
Perceived difficulty of regime .65    
 
 
Measurement and Structural Invariance 
To determine if the Information-Motivation-Behavioral Skills constructs (Fisher & Fisher, 
1992) found in the preliminary PCA had measurement invariance and structural invariance over 
time (i.e., at baseline, week 24, and week 48), a confirmatory factor analysis (CFA) was 
conducted using Mplus v. 6.12 (Muthén &Muthén, 1998-2011). Maximum likelihood (ML) 
estimation was used for all analyses because it has been shown to be robust to nonnormality 
(Muthén & Muthén, 2009). Nested model comparisons were conducted using a combination of 
fit indices including the difference in the model χ2 values, RMSEA, CFI, and SRMR.   
Configural Invariance 
Initially, a configural invariance model was specified in which three correlated factors 
(i.e., the factor at three occasions) were estimated simultaneously. Following recommendations 
of Muthen and Muthen (1998) the second indicator’s loading was fixed to 1 and its intercept was 
fixed to 0 for each factor to identify the model. All factor variances, covariances, and means 
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were then estimated with the exclusion of the observed controlled motivation variable (as 
determined by the preliminary PCA).  The configural invariance model had acceptable fit. The 
modification indices suggested that ART medication knowledge was the largest source of the 
misfit and should be excluded. After doing so, the configural invariance model fit significantly 
better than the initial configural invariance model, Δχ2(87) = 137.22, p < .001. Model fit indices 
revealed good model fit (RMSEA = 0.057 90% CI = 0.049-0.066, CFI = .912, SRMR = .080). 
The analysis proceeded by applying parameter constraints in successive models to examine 
potential decreases in fit resulting from measurement or structural non-invariance over the three 
occasions.  
Metric Invariance 
Equality of the indicator factor loadings across three occasions was then examined in a 
metric invariance model.  All factor loadings were constrained equal across time; all intercepts 
(except for the second item) and residual variances were still permitted to vary across time. 
Factor covariances and residual covariances were estimated as described previously.  The metric 
invariance model did not fit any less well than the configural invariance model Δχ2(73) = 89.4, p 
> .05.  The modification indices suggested that the loading of perceived difficulty of regime was 
a source of misfit and should be freed. After doing so, the partial metric invariance model fit 
significantly better than the full metric invariance model, Δχ2(1) = 29.32, p < .05. Alternative fit 
indices revealed adequate model fit (RMSEA = 0.057 90% CI = 0.049-0.065, CFI = .91). The 
fact that metric invariance (i.e., “weak invariance”) held indicates that the indicators were related 
to the latent factor equivalently across time, or more simply, that the same latent factor was being 
measured at each occasion (with the exception of controlled motivation and ART medication 
knowledge). 
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Scalar Invariance 
Equality of the unstandardized indicator intercepts across time was then examined in a 
scalar invariance model.  All factor loadings and indicator intercepts were constrained equal 
across time (except for controlled motivation, ART medication knowledge, and perceived 
difficulty of regime at time 3); all residual variances were still permitted to differ across time. 
Factor covariances and residual covariances were estimated as described previously. The scalar 
invariance model fit significantly better than the partial metric invariance model, Δχ2(13) = 58.99, 
p < .001. Alternative fit indices demonstrated adequate model fit (RMSEA = 0.062 90% CI = 
0.054-0.069, SRMR = .090). The fact that scalar invariance (i.e., “strong invariance”) held 
indicate that week 24 and 48 data have the same expected response for each indicator at the level 
of the trait, and that the observed differences in the indicator means between week 24 and 48 are 
due to factor mean differences only.  
Residual Invariance 
Equality of the unstandardized residual variances across time was then examined in a 
residual variance invariance model.  All factor loadings, item intercepts, and residual variances 
(except for control motivation, ART medication knowledge, and perceived difficulty of regime) 
were constrained to be equal across groups.  Factor covariances and residual covariances were 
estimated as described previously.  The residual variance invariance model did not fit better than 
the last scalar invariance model, Δχ2(16) = 20.89, p > .05.  The fact that residual variance 
invariance (i.e., “strict invariance”) did not hold indicates that the amount of indicator residual 
variance was not the same across weeks 24 and 48.  
In conclusion, these analyses showed that partial measurement invariance was obtained 
over time. The relationships of the indicators to the latent factors of the IMB model were 
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equivalent at week 24 and 48. These analyses also revealed that partial structural invariance was 
obtained over time, such that the same amount of individual differences variance in IMB 
constructs was observed with equal covariance over time across occasions. Model fit indices for 
all models are given in Table 10.  The observed variables that comprised each latent construct 
are listed in Table 11.  
Table 10. Model fit summary of measurement and structural invariance testing 
 χ2 (df) CFI SRMR RMSEA (90 % CI) Δχ2 (df) ΔCFI ΔRMSEA 
Configural 721.92 (437) .899 .083 .057 (.049-.064) - - - 
Partial 
Configural 
584.70 (350) .912 .080 .057 (.049-.066) -137.22 (87) .013 0 
Metric 632.52 (364) .899 .090 .060 (.052-.068) 47.82 (14) -.013 .003 
Partial 
Metric 
606.20 (363) .91 .087 .057 (.049-.065) -26.32 (1) .01 -.003 
Scalar  665.20 (376) .89 .09 .062 (.054-.069) 58.99 (13) -.02 .005 
Residual 686.10 (392) .89 .14 .06 (.053-.068) 20.90 (16) 0 -.001 
 
Table 11. Observed variables included in invariant IMB constructs  
Information Motivation Behavior Skills (48 weeks only) 
Concern for adherence Motivation to adhere Patient reasons for nonadherence 
Knowledge about ART Autonomous motivation Medication reasons for 
nonadherence 
Perceived Difficulty of 
Regime 
Self-efficacy to adhere Logistical reasons for 
nonadherence 
 Autonomy support from 
providers 
 
 Necessity for adherence   
 
Primary Analysis 
Following the recommendation of Preacher, Zhang, and Zyphur (2010) mediation was 
assessed using a multilevel mediation model. A 2-1-1 design was used to assess mediation and 
multiple mediators were examined simultaneously (Preacher & Hayes, 2008). Indicator coding 
was used to dummy code the three intervention groups to represent comparisons of interest to 
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allow for simultaneous hypothesis testing (Hayes & Preacher, 2013). The three levels were 
transformed into two variables: Contrast 1 and Contrast 2. Contrast 1 compared SC with the 
other two groups assigning the value of -0.667 to SC and the other two groups were given a 
value of 0.333.  Contrast 2 compared MI-CBT and MI-CBT/mDOT by assigning the value of -
0.5 and 0.5, respectively.  As recommended, values were kept within 1 to ease interpretation 
(Hayes & Preacher, 2013).  Potential mediators were self-reported information, motivation, and 
behavioral skill factors.  However the behavioral skill construct was only assessed for 48 week 
data as there was no behavioral skill construct that was found to be invariant for 24 week data 
because reasons for nonadherence was not measured at this time point.  
To test the mediated effects, a multicategorical, multiple mediator path model using MLR 
estimator was conducted.  Mplus was used to calculate the variance, standard error, and odds 
ratios for the indirect effects to determine statistical significance.  Significant indirect effects 
indicated which mediators were impacted by treatment and which mediators impacted adherence.  
As shown in Figure 6, the path models included: (1) paths between the intervention group and 
potential mediators, and (2) paths from the potential mediators to adherence.  
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Figure 6. Conceptual mediation model      
Mediational Models 
 The first model examined the effect that occurred to week 24 information and motivation 
constructs as a result of the intervention and simultaneously assessed the potential mediator 
effects on week 24 adherence. The estimated model is shown in Figure 7.  
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Figure 7. Mediational model examining the information and motivation constructs as mediators 
between intervention and week 24 adherence. All parameter estimates are unstandardized. SC = 
standard care; MI-CBT = motivational interviewing-cognitive behavioral therapy only; MI-
CBT/mDOT = motivational interviewing-cognitive behavioral therapy with modified directly 
observed therapy. *p < 0.05    
 A significant intervention effect on information was found for both contrasts, as 
participants in the treatment conditions were less likely to have adherence information than 
participants in the SC condition, (b = -0.17, SE = 0.075, β = -0.25, p < .05), and participants who 
received MI-CBT with mDOT were also less likely to have adherence information than 
participants who received MI-CBT only, (b = -0.20, SE = 0.09, β = -0.25, p = .01). A significant 
intervention effect was also found on motivation, as participants in the treatment conditions were 
more likely to have motivation to adhere than participants in the SC condition, (b = 0.49, SE = 
0.21, β = 0.18, p < .05), and participants who received MI-CBT with mDOT were also more 
likely to have motivation to adhere than participants who received MI-CBT only, (b = 0.46, SE = 
0.23, β = 0.15, p < .05). No significant effects were found on week 24 adherence. 
 To better understand the significant intervention effects found for contrast 1, an 
additional model examined the effect on week 24 information and motivation between each 
 51 
 
treatment condition and SC (see Figure 8).  Significant intervention effects on information and 
motivation were found for contrast 2 (comparing MI-CBT/mDOT and SC), as participants in the 
MI-CBT/mDOT condition were less likely to have adherence information, (b = -0.31, SE = 0.11, 
β = -0.40, p < .01), and more likely to have motivation to adhere than participants in the SC 
condition, (b = 0.78, SE = 0.27, β = 0.26, p < .01). 
 
 
 
Figure 8. Additional mediational model examining the effect between treatment conditions and 
SC on information and motivation constructs. All parameter estimates are unstandardized. *p < 
0.05   
 The next model examined the effect on week 24 information and motivation constructs as 
a result of the intervention and simultaneously assessed the potential mediator effects on week 48 
adherence. As shown in in Figure 9, the intervention effects were replicated on the information 
and motivation constructs as shown in the first model. Similarly, no significant effects were 
found on week 48 adherence. 
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Figure 9. Mediational model examining the information and motivation constructs as mediators 
between intervention and week 48 adherence. All parameter estimates are unstandardized. *p < 
0.05    
 The final model examined the effect on week 48 information, motivation, and behavior 
skills constructs as a result of the intervention and simultaneously assessed these mediator effects 
on week 48 adherence. The estimated model is shown in Figure 9. There were no significant 
effects found as a result of the intervention. However, there was a significant effect between 
week 48 motivation and adherence, (b = 0.90, SE = 0.45, β = 0.39, p < .05).   
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Figure 10. Mediational model examining the information, motivation, and behavioral skills 
constructs as mediators between intervention and week 48 adherence. All parameter estimates 
are unstandardized. *p < 0.05 
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CHAPTER 6 
DISCUSSION 
 The preliminary analysis of Project MOTIV8 revealed three constructs that appeared 
consistent with the IMB model and modification indices that these constructs were stable at 
baseline and week 48.  The adherence information construct consisted of measures of Concerns 
for Adherence, Knowledge about ART, and Perceived Difficulty of Regime.  The adherence 
motivation construct included the Brief Motivation Scale, Adherence Self-efficacy, Necessity for 
Adherence, Autonomous Motivation, and Autonomy Support from Providers scales.  The 
behavioral skills construct was not obtained at week 24 due to variables (e.g., Self-efficacy for 
Adherence and Perceived Difficulty of Regime) failing to load on the construct and additional 
variables (e.g., Patient, Medication, and Logistical Reasons for Nonadherence) not being 
measured at this time point.  However, the construct was observed at baseline and week 48 and 
included measures of Patient, Medication, and Logistical Reasons for Nonadherence.  
 Although the three constructs that emerged are interpreted to be IMB constructs, the 
failure of some measures to load on the intended construct (e.g., Self-Efficacy to Adhere loading 
on the motivation rather than the behavioral skills construct and the Concerns for Adherence 
scale loading on the adherence information construct) suggests that alternative interpretations of 
the constructs may be valid (e.g., the motivation construct might be a combined 
motivation/confidence construct and the behavioral skills construct may be a self-report 
adherence measure). This highlights the difficulty with the lack of established measures for the 
IMB model.  Several studies have used the IMB model as a theoretical foundation to develop 
interventions, however the methodology used to assess and measure the IMB components have 
been variable (Leeman, Chang, Voils, Crandell, & Sandelowski, 2011; See Table 12).  Few 
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studies report how IMB constructs are measured.  Furthermore, there is little evidence to 
demonstrate that the measures used to represent IMB constructs are valid and invariant 
suggesting an area for much needed additional research. These limitations regarding 
measurement of the IMB constructs should be kept in mind when interpreting the main analyses. 
 The primary analysis revealed that MI-CBT/mDOT had significant effects on 
participants’ adherence information and motivation at week 24. Unexpectedly participants in the 
MI-CBT/mDOT condition had lower levels of adherence information relative to participants in 
the other treatment groups. With respect to motivation MI-CBT/mDOT participants had higher 
scores than participants in the other groups.  There were no significant effects of the mediator 
variables on adherence at week 24.  In addition, the intervention did not affect any of the IMB 
mediator constructs at week 48.  However, adherence motivation at week 48 was significantly 
related to increased adherence at week 48.  
Our results revealed limited intervention effects on the potential mediators, which may be 
due to unsuccessful intervention strategies.  Further, the majority of our potential mediators were 
not associated with adherence suggesting that our theoretical assumptions about the active 
components of the intervention were not entirely valid.  The IMB model of behavior change 
(Fisher & Fisher, 1992) suggests that information, motivation, and behavioral skills are critical 
targets for promoting adherence behavior.  Based on this framework, these three constructs were 
targeted with the assumption that by impacting adherence related information, motivation, and 
behavioral skills, ART adherence would, in turn, improve.  
 The use of CBT targeted the adherence information component (e.g., adherence 
knowledge discussed during counseling session) to enhance knowledge for adherence.  However, 
the results demonstrated that intervention strategies to target adherence information were not 
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effective.  As indicated the combined MI-CBT/mDOT treatment appeared to diminish 
knowledge of adherence related information. There was also no significant effect of receiving 
MI-CBT on adherence information relative to SC. The negative effect of MI-CBT/mDOT may 
have been because participants who received mDOT may have relied on project staff and 
therefore retained less of the provided adherence information.  This is consistent with prior work 
which indicates the removal of DOT leads to declines in adherence (Berg, Litwin, Li, Heo, & 
Arnsten, 2011).  Participants receiving mDOT may have focused less on adherence related 
information because they received repeated visits from staff and received cues to take their 
medications. Nevertheless, MI-CBT’s failure to enhance knowledge relative to SC suggests 
either that SC provided effective knowledge or that MI-CBT was ineffective in enhancing 
knowledge.  Examination of the means for the adherence information scales across all 
participants suggests that their knowledge about ART did not increase and they did not perceive 
their regimes to be difficult.  
 Motivation was targeted with the use of MI techniques in both treatment groups, however 
the results demonstrated that only the MI-CBT/mDOT condition had a significant effect on 
levels of adherence motivation.  MI-CBT/mDOT enhanced motivation relative to both MI-CBT 
and SC at week 24 although this effect was not sustained at week 48.  The lack of an effect of 
MI-CBT alone on adherence motivation relative to SC indicates the observed motivational 
effects in this study were due to the mDOT rather than MI-CBT portion of the treatment.  This 
suggests that daily contact with supportive project staff may have served to enhance participants’ 
motivation for adherence (Bradley-Ewing, Thomson, Pinkston, & Goggin, 2008) over and above 
any effect of the MI components. Nevertheless, it is surprising that the MI intervention 
component (alone) did not have a positive effect relative to SC.  
 57 
 
 Prior research studies that developed IMB based interventions have failed to examine 
whether motivation mediated the relationship between the intervention and ART adherence. 
Nevertheless, the broader literature on the effectiveness of MI for increasing motivation and 
fostering behavior change for adherence (Ingersoll et al., 2011; Parsons, Golub, Rosof, & 
Holder, 2007; Safren et al., 2001) suggests this finding is anomalous. Perhaps the most likely 
explanation for the lack of effect found between MI-CBT and motivation is that baseline 
motivation levels were very high (e.g., M = 9.34). This suggests that MI-CBT counseling did not 
enhance participants’ motivation because motivation levels were consistently high throughout 
the study and there was little room to change or improve motivation. Only the regular direct 
intervention of staff in the form of mDOT was able to increase already high levels of motivation. 
 With regard to the effect of the treatments on behavioral skills, our preliminary analysis 
indicated that self-efficacy for adherence and perceived difficulty of regime variables failed to 
load on the adherence behavioral skills construct. This suggests that the measures used may not 
have appropriately represented the adherence behavioral skills construct as hypothesized.  As 
shown in the CFA, self-efficacy for adherence appeared to be reflecting the invariant motivation 
construct while reasons for nonadherence accurately represented behavioral skills and was 
invariant at baseline and 48 weeks, but was not measured at week 24. To address measurement 
concerns, future intervention studies should identify measures that can be used to validly assess 
behavioral skills and these measures need to be assessed at all key time points.  
Due to the lack of invariant measure of behavioral skills that was measured at week 24 
the effect of the interventions on behavioral skills could only be examined in the long term. Our 
results at week 48 suggest the modules focused on enhancing behavioral skills may not have 
been effective or strong enough to impact participants’ skills in the long run, as with the other 
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two IMB constructs. Because of the lack of available week 24 data it is unclear whether the 
interventions had any effect in the short run.  
 To our knowledge, this is the first study to assess the role of potential mediators in an 
IMB based intervention to improve ART adherence.  Few studies have used appropriate 
statistical techniques to assess mediation in intervention research (Leeman, Chang, Voils, 
Crandell, & Sandelowski, 2011; Preacher, Zhang, & Zyphur, 2010).  More importantly, even 
fewer studies have evaluated the role of mediators in efficacy studies that have failed to 
demonstrate significant main effects.  To improve the efficacy of interventions, an assessment of 
theoretical mediators in intervention studies with and without significant effects is necessary to 
inform future research on effective and ineffective treatment components (Glasgow, 2002; 
Kraemer et al., 2002).   
 Although there are no prior studies evaluating the role of potential mediators in IMB 
based interventions for ART adherence, one prior study used a mixed-methods approach to 
identify and test potential mediators of ART adherence by integrating results across intervention 
and quantitative observational studies (Leeman, Chang, Voils, Crandell, & Sandelowski, 2011). 
Their results suggested that current drug/alcohol use, satisfaction with social support, emotional 
wellbeing, positive forms of coping, self-efficacy, locus of control, knowledge of HIV treatment, 
and satisfaction with healthcare provider are all potential mediators of ART adherence 
interventions.  These findings include some IMB related variables but because of the lack of a 
coherent theoretical framework such as the IMB model it is difficult to reconcile these results 
with the present study. A recent review of research using the IMB for a variety of health 
problems included six studies focused on increasing ART adherence for individuals with 
HIV/AIDS (Margolin, Avants, Warburton, Hawkins, & Shi, 2003; Parsons, Golub, Rosof, & 
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Holder, 2007; Pearson, Micek et al., 2007; Purcell et al., 2007; Sabin et al., 2010; Wagner et al., 
2006). Five of the six studies demonstrated significantly higher adherence for treatment 
conditions compared to the control conditions and effective intervention techniques included the 
use of interactive discussion and counseling for the adherence information construct, the use of 
counseling and MI techniques to enhance personal motivation, and the use of role-playing and 
skill-building modules to enhance behavioral skills.  However, similar to our findings, other 
studies have failed to impact ART adherence using this model (Purcell et al., 2007; Sampaio-Sa 
et al., 2008; Wagner et al., 2006).  Unfortunately many randomized controlled trials that have 
developed their interventions based on the IMB model fail to describe how their interventions 
target the various components of the IMB model and also fail to measure the impact of their 
intervention on the IMB constructs (see Table 12).  Only one study in the review (Margolin, 
Avants, Warburton, Hawkins, & Shi, 2003) provided information on how they measured the 
IMB constructs and how these variables were affected pre and post-treatment.  Mean values of 
the IMB variables increased for both treatment conditions over time, however only participants 
who were in the HIV harm reduction program (HHRP) condition demonstrated significantly 
more improvements in sex-related and drug-related behavioral skills.    
 Our findings suggest that Project MOTIV8 may not have been effective at enhancing 
ART adherence because the novel MI-CBT/mDOT intervention may have included ineffective 
strategies to target adherence information and behavioral skills or contained other treatment 
components (i.e., observed therapy) that undermined the effects of these strategies. Given that 
the CBT has well-established empirical support it may be more plausible that its effects were 
undermined by the mDOT component.  The treatment conditions failed to impact adherence 
information and adherence behavioral skills were poorly defined and measured.  MI-CBT did not 
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have an effect on motivation suggesting that MI counseling may not be effective for individuals 
presenting with high levels of motivation.  However, mDOT did significantly enhance levels of 
motivation, but similar to previous research this impact may not have been strong enough to 
continue after treatment (Berg, Litwin, Li, Heo, & Arnsten, 2011).   
   In conclusion, our findings suggest that future studies should determine which measures 
to use to validly and reliably assess IMB constructs and assess whether these constructs are 
invariant across time. Moreover, it would be desirable to develop objective measures for the 
assessment of adherence behavioral skills rather than relying on indirect measures that focus on 
participants’ levels of self-efficacy, perceived difficulty of regime, and reasons for nonadherence.  
 Future intervention studies that plan to use MI-CBT counseling to target motivation 
should assess participants’ baseline levels motivation as MI counseling may not be effective with 
highly motivated participants. Additionally, mDOT may not be an effective intervention to 
enhance information or retain motivation as repeated cues may diminish the impact on 
information and motivation wasn’t sustained.  Our results suggest that mDOT may not be an 
effective intervention for individuals living with HIV or living with any chronic condition as its 
effects diminish after treatment is discontinued.  These findings demonstrate the various 
components that need to be considered when developing and assessing intervention research.  
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APPENDIX A 
A-1. Randomized controlled trials that have used the IMB model to impact ART adherence 
Study Treatment Conditions Measurements Used Outcome 
1 Enhanced Methadone Maintenance 
Program (EMMP)- 
Received 6 months of standard 
treatment 
(daily methadone and weekly 
individual substance abuse 
counseling and case management) 
enhanced by the inclusion of a 6-
session HIV risk reduction 
intervention that included (a) an 
individualized feedback session 
designed to increase motivation for 
behavior change, (b) a video 
demonstration 
of needle cleaning with bleach and 
correct use of condoms (c) practice 
cleaning a needle with bleach and 
applying condoms to a penis 
replica, (d) harm reduction 
negotiation role playing, (e) the 
provision of harm reduction kits 
(including needle exchange 
locations, bleach, alcohol swabs, 
male and female condoms, and 
step-by-step instructions), and (f) 
an emphasis on the importance of 
sharing harm reduction knowledge 
and skills with others in their social 
network 
 
HIV_ Harm Reduction Program 
(HHRP)- 
Received all components of E-
MMP and attended group therapy 
2x week. Content matter was 
comprehensive to address the 
medical, emotional, and spiritual 
needs of individuals living 
with HIV. Group topics included 
harm reduction skills training; 
relapse prevention; improving 
emotional, social, and spiritual 
health, increasing medication 
adherence; active participation in 
Information –  
16-item AIDS Information Sheet 
(inter item reliability = .72).  
 
Motivation –  
12-item (measuring confidence in 
efficacy, intention to use, social 
norms for use, and perceived 
difficulty) for each of three harm 
reduction behaviors: condom use, 
not sharing needles, and using new 
or bleach-cleaned needles.  
 
Behavioral skills –  
Demonstrated cleaning a needle 
with bleach and selecting and 
applying a latex condom using a 
penis replica; sessions were 
videotaped, tapes were rated by 
research staff blind to treatment 
assignment (interrater reliability 
= .98), and the percentage of steps 
performed correctly was 
calculated.  
 
Adherence –  
Measured weekly to assess # of 
missed doses, Adequate adherence 
was defined as greater than or 
equal to 95%. 
 
 adherence for 
participants in 
HHRP than EMMP, 
F(1, 67) = 5.67, p 
= .02, partial 2 
= .08. 
 
Significantly more 
patients assigned to 
HHRP reported  
 95% adherence 
during the treatment 
phase of the study 
than patients 
assigned to E-MMP 
(OR = 2.74, p =.04; 
CI =1.03–7.27).  
 
Mean values of IMB 
variables increased 
for both treatment 
conditions over 
time, however only 
participants who 
were in the HIV 
harm reduction 
program (HHRP) 
condition 
demonstrated 
significantly more 
improvements in 
sex-related and 
drug-related 
behavioral skills. 
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medical care; and making healthy 
lifestyle choices. Each group 
session lasted 2 hrs.  
Margolin, A., Avants, S. K., Warburton, L. A., Hawkins, K. A., & Shi, J. (2003). A randomized clinical 
trial of a manual-guided risk reduction intervention for HIV-positive injection drug users. Health 
Psychology: Official Journal of the Division of Health Psychology, American Psychological Association, 
22(2), 223–228. 
2 Intervention –   
Sessions focused on the delivery of 
factual information and the use of 
MI techniques to enhance 
motivation, promote personal 
responsibility for improving 
adherence and reducing alcohol 
use, and develop individualized 
behavior change plans, received 
individualized feedback and was 
provided with a wallet-sized card to 
facilitate self-monitoring of 
adherence and drinking behaviors, 
received tailored skills-building 
modules, modules included a 
didactic portion, a self-assessment, 
skills-building activities, 
opportunities to practice, and 
suggested take-home activities, 
relapse prevention to reinforce 
skills that had been developed, gain 
insight about participant 
experiences, and facilitate access to 
community based resources.  
 
Education –  
The education condition was 
matched to the intervention for time 
and content. Participants attended 8 
sessions facilitated by a health 
educator focused on the provision 
of factual information through 
didactic methods and structured 
discussions about videotapes 
pertaining to HIV, HAART 
adherence, and alcohol. 
Information, motivation, and 
behavior skills measures were not 
reported. 
 
 
Adherence was assessed using a 
timeline follow-back interview to 
recall, day by day, all medication 
doses taken and missed during the 
past 2 weeks. 
 percent dose 
adherence 
for participants in 
the intervention 
condition, F(1, 107) 
= 4.0; p = 0.05] and 
in percent day 
adherence, F(1, 111) 
= 4.1; p = 0.05] 
compared with 
participants in the 
education condition 
at 3 months but was 
not sustained at 6 
months.  
 
 
On average, percent 
dose adherence for 
individuals in the 
intervention 
condition increased 
14.6% (SD = 
26.3%), whereas 
percent dose 
adherence for 
individuals in the 
education condition 
increased only 4.3% 
(SD = 26.5%). 
Parsons, J. T., Golub, S. A., Rosof, E., & Holder, C. (2007). Motivational interviewing and cognitive-
behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized 
controlled trial. Journal of Acquired Immune Deficiency Syndromes (1999), 46(4), 443–450. 
3 Intervention –  
Peers individually administered the 
6-week mDOT 
intervention at the Clinic to mDOT 
Information, motivation, and 
behavior skills measures were not 
reported. 
 
   90% adherence 
in mDOT 
participants than the 
standard-care 
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participants 
during their morning weekday 
dose. Evening and weekend doses 
were not observed. Nighttime and 
weekend doses were self 
administered. As part of the daily 
interaction with participants, peers 
provided social support, 
information about the benefits and 
side effects of HAART, how to 
address stigma’s effect on 
adherence, and encouragement to 
participate in community support 
groups. 
 
Standard Care –  
Includes no-cost medications, 
clinical and laboratory follow-up, 
psychosocial adherence support by 
a trained social worker, and referral 
to community-based peer support 
groups. Mandatory pre-HAART 
counseling involves education 
about 
dosing, side effects, nutritional 
requirements, and the importance 
of adherence. 
Adherence –  
The percentage of prescribed 
HAART medication doses taken at 
6 and 12 months with the 
commonly used question ‘‘How 
many of your HIV medication 
doses did you miss in the last 7 
days?’’ A similar wording with a 
30-day assessment period also was 
included. 
participants to 
achieve at 6 months 
(7-day measure: 
92% mDOT vs. 
85%, OR = 2.0, 95% 
CI: 0.93, 4.5; 30-day 
measure: 92% 
mDOT vs. 87%, OR 
= 1.9, 95% CI: 0.83, 
4.3). 
Pearson, C. R., Micek, M. A., Simoni, J. M., Hoff, P. D., Matediana, E., Martin, D. P., & Gloyd, S. S. 
(2007). Randomized control trial of peer-delivered, modified directly observed therapy for HAART in 
Mozambique. Journal of Acquired Immune Deficiency Syndromes (1999), 46(2), 238–244. 
http://doi.org/10.1097/QAI.0b013e318153f7ba 
4 Peer Mentoring Intervention –  
Received sessions 2x/week for 5 
weeks, 7 group  
2 individual sessions, and 1 ‘‘peer 
volunteer activity’’ (PVA), during 
which participants went to a local 
service organization for 2 to 4 
hours to observe, participate, and 
practice peer mentoring skills. 
Session topics included: the power 
of peer mentoring, utilization of 
HIV primary care and adherence, 
sex and drug risk behaviors. The 
final group session focused on 
review and reinforcement of 
motivation and skills for behavior 
change and ended with a graduation 
ceremony. 
 
Video Discussion Intervention –  
Information, motivation, and 
behavior skills measures were not 
reported. 
 
Adherence –  
Self-report of number of doses of 
antiretroviral medication 
prescribed and number of doses 
missed in the previous day and the 
previous week. Defined as number 
of doses taken divided by number 
of doses prescribed. 
Participants in both 
conditions 
reported no change 
in medical care and 
adherence, and there 
were no significant 
differences between 
conditions. 
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Received 8 group sessions with 
topics related to basic HIV 
prevention information, watched 
documentary or self-help videos 
focused on issues relevant to HIV-
positive injection drug users (e.g., 
prejudice and discrimination, 
getting a job, incarceration, Red 
Cross safety tips, overdose 
prevention), followed by facilitated 
discussion.  
Purcell, D. W., Latka, M. H., Metsch, L. R., Latkin, C. A., Gómez, C. A., Mizuno, Y., … INSPIRE Study 
Team. (2007). Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV 
transmission and increase access to care and adherence to HIV medications among HIV-seropositive 
injection drug users. Journal of Acquired Immune Deficiency 
5 Intervention –  
Participants found to be less than 
95% adherent according to the 
EDM data were ‘flagged’ for 
counseling with a clinic physician 
or nurse. The data were provided to 
both the subject and his/her 
clinician as a printout summarizing 
the percent of doses taken, the 
percent of doses taken on time, 
and a visual display of doses taken 
by time. This process of flagging 
and counseling was specific to each 
clinic visit, such that if a subject 
was counseled in Month 8 but had 
EDM-measured adherence C95% at 
the Month 9 visit, no flagging for 
counseling occurred. In each 
counseling session, the clinician 
reviewed the EDM printout with 
the subject, explored reasons for 
missed or off-time doses, and 
inquired about problems or 
challenges the subject might be 
having. 
 
Control –  
In the control arm, subjects 
continued to provide their EDM 
data to a study team member at 
their monthly visits, but these data 
remained blinded to both subjects 
and clinicians. However, control 
subjects whose monthly written 
self-reports indicated 95% 
adherence were also flagged by a 
Information, motivation, and 
behavior skills measures were not 
reported. 
 
Adherence –   
Measured by EDM and self-report; 
a visual analog scale (VAS) of 
proportion of ART medications 
taken in the previous month; a 
series of 6 yes/no questions about 
medication-taking behavior in the 
previous month (being careless, 
forgetting, stopping treatment due 
to feeling better, not taking 
medications while at work, taking 
pills early or late, sharing 
medications); and two quantitative 
questions on the number of days 
medications were not taken and 
number of days medications were 
taken early or late. 
 mean adherence in 
intervention 
condition than 
controls at month 
12: 96.5 vs. 84.5% 
(t-test statistic = -
3.20; p = 0.003 
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study team member for further 
counseling with a 
clinician. Thus, subjects in both 
groups whose adherence in the 
previous month appeared to be 
below 95% were identified for 
counseling, with the difference 
being the flagging mechanism—
EDM for intervention subjects and 
self-reported adherence for 
controls. In the counseling sessions 
with control subjects, which were 
guided by self reported adherence, 
the standard of care in China, 
clinicians were similarly advised to 
inquire about recent problems that 
might have affected adherence. 
Sabin, L. L., DeSilva, M. B., Hamer, D. H., Xu, K., Zhang, J., Li, T., … Gill, C. J. (2010). Using 
electronic drug monitor feedback to improve adherence to antiretroviral therapy among HIV-positive 
patients in China. AIDS and Behavior, 14(3), 580–589. http://doi.org/10.1007/s10461-009-9615-1 
6 Participants were randomized to 
one of three 
groups: (1) a five-session training 
intervention that combines 
cognitive-behavioral components 
and a 2-week practice trial 
(enhanced intervention); (2) the 
same intervention as above but 
without the practice trial 
(cognitive–behavioral 
intervention); or (3) no 
intervention, but usual clinical care. 
 
CBT with Practice Trial –  
Received education about HIV, 
ART and the importance of 
adherence, tailored regimen to daily 
routine, problem-solving skills to 
overcome identified adherence 
barriers, reframing beliefs and 
attitudes about treatment to increase 
adherence self-efficacy, and 
facilitating positive social support 
for adherence. Received a 2-week, 
pre-ART placebo practice trial that 
simulates the challenges of ART 
adherence, with the exception of 
treatment side-effects. 
 
CBT only –  
Same as above without Practice 
Information, motivation, and 
behavior skills measures were not 
reported. 
 
Adherence – 
Measured by EDM and self-report; 
Participants reported the number of 
doses taken and missed for each 
antiretroviral over the previous 3 
days 
Adherence between 
the two intervention 
groups did not 
differ. Up to week 
24, the mean 
percentage of doses 
taken by patients of 
the intervention 
group remained at 
90% or above, 
compared with 
nearly 80% in the 
control group. 
However, 
participants in the 
control group had 
better adherence at 
week 48 although 
this difference was 
not significant. 
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Trial 
 
Standard Care –  
Received education about the 
importance of adherence and 
regimen’s dosing instructions; 
tailored regimen information to 
daily routine; and was offered a pill 
box. Follow-up visits were 
scheduled every 3 months (or more 
frequently as clinically indicated), 
and procedures related to 
adherence typically consisted of 
inquiries about side 
effects and whether the patient was 
taking all prescribed doses. 
Wagner, G. J., Kanouse, D. E., Golinelli, D., Miller, L. G., Daar, E. S., Witt, M. D., … Haubrich, R. H. 
(2006). Cognitive-behavioral intervention to enhance adherence to antiretroviral therapy: a randomized 
controlled trial (CCTG 578). AIDS (London, England), 20(9), 1295–1302. 
http://doi.org/10.1097/01.aids.0000232238.28415.d2 
7 Intervention –   
Received 4 counseling sessions 
lasting 2–3 hours each on topics 
related to disease and markers of 
clinical progression, practical 
treatment, nutrition,  
support, tailoring regimens to 
lifestyle, managing side effects of 
medication, developing ways to 
improve interaction with care staff, 
methods to address and remove 
barriers to adherence, create social 
support conducive to adherence 
behaviors, use stress management 
strategies, and to increase self-
monitoring and managing 
adherence lapses.  
 
Control –  
Participated in four 8–12-min video 
education sessions over a 2-month 
period. The videos were didactic 
descriptions of HIV transmission, 
natural history of the disease and 
markers of clinical progression, 
practical treatment issues and 
questions about nutrition and 
psychological support. Following 
the video, participants were able to 
ask questions of an infectious 
disease specialist 
Information on knowledge and 
beliefs about AIDS and ART, and 
psychosocial measures were only 
measured at baseline by 
conducting face-to-face interviews 
 
Adherence –  
Self-reported ART adherence was 
measured and calculated as a 
percentage of doses taken divided 
by doses prescribed, using 4-day 
structured questions (ACTG; 
Chesney et al. 2000), perfect 
adherence was considered to be 
95% or higher. Pharmacy record 
adherence estimates were 
evaluated using drug possession 
ratios. Drug possession ratios were 
calculated as the number of days of 
medication supplied (30 days) 
divided by the number of days 
between pharmacy dispensations. 
There were no 
differences in self-
reported adherence 
between participants 
who were in the 
intervention group 
and the control 
group. 
 
No differences were 
found in adherence 
measured by 
pharmacy records 
and medication 
possession ratios 
between groups. 
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who had extensive experience in 
the care and counseling of patients 
with AIDS. 
Sampaio-Sa, M., Page-Shafer, K., Bangsberg, D. R., Evans, J., Dourado, M. de L., Teixeira, C., … Brites, 
C. (2008). 100% adherence study: educational workshops vs. video sessions to improve adherence among 
ART-naïve patients in Salvador, Brazil. AIDS and Behavior, 12(4 Suppl), S54–62. 
http://doi.org/10.1007/s10461-008-9414-0 
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